曾子航,李荷蕊,戴中上,陈燕

• 1:中南大学湘雅二医院呼吸与危重症医学科

摘要(Abstract)：

呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)检测是一种定量、非侵入性、简便安全的气道炎症测量方法,随着美国胸科学会/欧洲呼吸学会指南对测量技术的标准化,FeNO作为哮喘的管理工具之一,已被广泛用于临床检测以嗜酸性粒细胞浸润为主的气道炎症,评估吸入糖皮质激素的疗效。而对于慢性阻塞性肺疾病(慢阻肺)而言,虽然已开展了一些初步研究,但现有研究结论存在诸多争议和冲突,单一FeNO在慢阻肺中的临床应用价值尚难定论。然而,通过模拟肺内NO气体交换构建的NO动力学模型对FeNO进行扩展分析能够获取更多信息,有助于定位气道炎症,为慢阻肺的评估和管理增加新的维度。本文回顾近年扩展FeNO分析在气道疾病中的相关研究,归纳总结FeNO参数在慢阻肺诊疗中的研究现况。

关键词(KeyWords)： 呼出气一氧化氮;慢性阻塞性肺疾病;气道炎症

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(81873410)

作者(Author): 曾子航,李荷蕊,戴中上,陈燕

参考文献(References)：

• [1]Global Initiative for Chronic Obstructive Lung Disease(GOLD).Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease(2017 report)[EB/OL].[2018-12-20]http://goldcopd.org/download/326/wms-GOLD-2017-FINAL.pdf(accessed March 19,2018).
• [2]GBD 2015 Chronic Respiratory Disease Collaborators.Global,regional,and national deaths,prevalence,disability-adjusted life years,and years lived with disability for chronic obstructive pulmonary disease and asthma,1990-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet Respir Med,2017,5(9):691-706.
• [3]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J].Lancet Respir Med,2018,391(10131):1706-1717.
• [4]Yoon HI,Sin DD.Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease:a critical review of the literature[J].Drugs,2011,71(14):1821-1837.
• [5]Han MK,Agusti A,Calverley PM,et al.Chronic obstructive pulmonary disease phenotypes:the future of COPD[J].Am JRespir Crit Care Med,2010,182(5):598-604.
• [6]Rennard SI,Vestbo J.The many"small COPDs":COPD should be an orphan disease[J].Chest,2008,134(3):623-627.
• [7]Gustafsson LE,Leone A,Persson M,et al.Endogenous nitric oxide is present in the exhaled air of rabbits,guinea pigs and humans[J].Biochem Biophys Res Commun,1991,181(2):852-1857.
• [8]Barnes PJ,Dweik RA,Gelb AF,et al.Exhaled nitric oxide in pulmonary diseases:a comprehensive review[J].Chest,2010,138(3):682-692.
• [9]Saleh D,Ernst P,Lim S,et al.Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase:effect of inhaled glucocorticoid[J].Faseb J,1998,12(11):929-937.
• [10]Brindicci C,Kharitonov S,Ito M,et al.Nitric oxide synthase isoenzyme expression and activity in peripheral lungs of COPDpatients[J].Am J Respir Crit Care Med,2010,181(1):21-30.
• [11]Brindicci C,Ito K,Resta O,et al.Exhaled nitric oxide from lung periphery is increased in COPD[J].Eur Respir J,2005,26(1):52-59.
• [12]Maarsingh H,Leusink J,Bos IS,et al.Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma[J].Respir Res,2006,7:6.
• [13]Wang Z,Pianosi P,Keogh K,et al.The Clinical Utility of Fractional Exhaled Nitric Oxide(FeNO)in Asthma Manag ement[EB/OL].[2018-12-20]https://www.ncbi.nlm.nih.gov/books/NBK487497/
• [14]Tsoukias NM,George SC.A two-compartment model of pulmonary nitric oxide exchange dynamics[J].J Appl Physiol,1998,85(2):653-666.
• [15]Jorres RA.Modelling the production of nitric oxide within the human airways[J].Eur Respir J,2000,16(3):555-560.
• [16]George SC,Hogman M,Permutt S,et al.Modeling pulmonary nitric oxide exchange[J].J Appl Physiol,2004,96(3):831-839.
• [17]Horváth I,Barnes PJ,Loukides S,et al.A European Respiratory Society technica standard:exhaled biomarkers in lung disease[J].Eur Respir J,2017,49(4).pii:1600965.
• [18]H?gman M,Lehtim?ki L,Dinh-Xuan AT.Utilising exhaled nitric oxide information to enhance diagnosis and therapy of respiratory disease-current evidence for clinical practice and proposals to improve the methodology[J].Expert Rev Respir Med,2017,11(2):101-109.
• [19]Antus B,Barta I,Horvath I,et al.Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations[J].Respirology,2010,15(3):472-477.
• [20]Bazeghi N,Gerds TA,Budtz-Jorgensen E,et al.Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD[J].Respir Med,2011,105(9):1338-1344.
• [21]de Laurentiis G,Maniscalco M,Cianciulli F,et al.Exhaled nitric oxide monitoring in COPD using a portable analyzer[J].Pulm Pharmacol Ther,2008,21(4):689-693.
• [22]Roy K,Smith J,Kolsum U,et al.COPD phenotype description using principal components analysis[J].Respir Res,2009,10:41.
• [23]Tilemann L,Gindner L,Meyer F,et al.Differences in local and systemic inflammatory markers in patients with obstructive airways disease[J].Prim Care Respir J,2011,20(4):407-414.
• [24]Santini G,Mores N,Shohreh R,et al.Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers[J].J Breath Res,2016,10(1):017102.
• [25]H?gman M,Holmkvist T,Wegener T,et al.Extended NOanalysis applied to patients with COPD,allergic asthma and allergic rhinitis[J].Respir Med,2002,96(1):24-30.
• [26]Roy K,Borrill ZL,Starkey C,et al.Use of different exhaled nitric oxide multiple flow rate models in COPD[J].Eur Respir J,2007,29(4):651-659.
• [27]Feng JX,Lin Y,Lin J,et al.Relationship between fractional exhaled nitric oxide level and efficacy of inhaled corticosteroid in asthma-COPD overlap syndrome patients with different disease severity[J].J Korean Med Sci,2017,32(3):439-447.
• [28]Dummer JF,Epton MJ,Cowan JO,et al.Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide[J].Am J Respir Crit Care Med,2009,180(9):846-852.
• [29]Kunisaki KM,Rice KL,Janoff EN,et al.Exhaled nitric oxide,systemic inflammation,and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease:a prospective study[J].Ther Adv Respir Dis,2008,2(2):55-64.
• [30]Logotheti H,Pourzitaki C,Tsaousi G,et al.The role of exhaled nitric oxide in patients with chronic obstructive pulmonary disease undergoing laparotomy surgery-the noxious study[J].Nitric Oxide,2016,61:62-68.
• [31]Liu J,Sandrini A,Thurston MC,et al.Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients[J].Respiration,2007,74(6):617-623.
• [32]Kobayashi S,Hanagama M,Yamanda S,et al.Inflammatory biomarkers in asthma-COPD overlap syndrome[J].Int J Chron Obstruct Pulmon Dis,2016,11:2117-2123.
• [33]Lehtim?ki L,Kankaanranta H,Saarelainen S,et al.Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD[J].Eur Respir J,2010,35(1):72-78.
• [34]Short PM,Williamson PA,Lipworth BJ.Effects of extra-fine inhaled and oral corticosteroids on alveolar nitric oxide in COPD[J].Lung,2012,190(4):395-401.
• [35]Gelb AF,Flynn Taylor C,Krishnan A,et al.Central and peripheral airway sites of nitric oxide gas exchange in COPD[J].Chest,2010,137(3):575-584.
• [36]Santus P,Radovanovic D,Mascetti S,et al.Effects of bronchodilation on biomarkers of peripheral airway inflamma tion in COPD[J].Pharmacol Res,2018,133:160-169.
• [37]Rawy AM,Mansour AI.Fraction of exhaled nitric oxide measurement as a biomarker in asthma and COPD compared with local and systemic inflammatory markers[J].Egypt JChest Dis Tuberc,2015,64(1):13-20.
• [38]Bhowmik A,Seemungal TA,Donaldson GC,et al.Effects of exacerbations and seasonality on exhaled nitric oxide in COPD[J].Eur Respir J,2005,26(6):1009-1015.
• [39]Huang SY,Chou PC,Wang TY,et al.Exercise-induced changes in exhaled no differentiates asthma with or without fixed airway obstruction from COPD with dynamic hyperinflation[J].Medicine(Baltimore),2016,95(15):e3400.
• [40]Rouhos A,Kainu A,Piirila P,et al.Repeatability of exhaled nitric oxide measurements in patients with COPD[J].Clin Physiol Funct Imaging,2011,31(1):26-31.
• [41]Mostafavi-Pour-Manshadi SM,Naderi N,Barrecheguren M,et al.Investigating fractional exhaled nitric oxide(FeNO)in chronic obstructive pulmonary disease(COPD)and asthmaCOPD overlap(ACO):a scoping review protocol[J].BMJOpen,2017,7(12):e018954.
• [42]Lu Z,Huang W,Wang L,et al.Exhaled nitric oxide in patients with chronic obstructive pulmonary disease:a systematic review and meta-analysis[J].Int J Chron Obstruct Pulmon Dis,2018,13:2695-2705.
• [43]Williamson PA,Clearie K,Menzies D,et al.Assessment of smallairways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD[J].Lung,2011,189(2):121-129.
• [44]Hirano T,Matsunaga K,Sugiura H,et al.Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD[J].J Breath Res,2013,7(4):046002.
• [45]Paredi P,Kharitonov SA,Meah S,et al.A novel approach to partition central and peripheral airway nitric oxide[J].Chest,2014,145(1):113-119.
• [46]Lehouck A,Carremans C,De Bent K,et al.Alveolar and bronchial exhaled nitric oxide in chronic obstructive pulmonary disease[J].Respir Med,2010,104(7):1020-1026.
• [47]Chen FJ,Huang XY,Liu YL,et al.Importance of fractional exhaled nitric oxide in the differentiation of asthma COPDoverlap syndrome,asthma,and COPD[J].Int J Chron Obstruct Pulmon Dis,2016,11:2385-2390.
• [48]Alcazar-Navarrete B,Romero-Palacios PJ,Ruiz-Sancho A,et al.Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes[J].Nitric Oxide,2016,54:67-72.
• [49]邓玎玎,周爱媛,双庆翠,等.呼出气一氧化氮测定对支气管哮喘-慢性阻塞性肺疾病重叠综合征的诊断价值[J].中华结核和呼吸杂志,2017,40(2):98-101.
• [50]Goto T,Camargo CJ,Hasegawa K.Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome:analysis of the national health and nutrition examination survey,2007-2012[J].Int J Chron Obstruct Pulmon Dis,2016,11:2149-2155.
• [51]Alcázar-Navarrete B,Castellano Mi?án F,Santiago Díaz P,et al.Alveolar and Bronchial Nitric Oxide in Chronic Obstructive Pulmonary Disease and Asthma-COPD Overlap[J].Arch Bronconeumol,2018,54(8):414-419.
• [52]夏清,潘频华,王展,等.呼出气一氧化氮检测在支气管炎症性肺疾病中的临床应用[J].中南大学学报(医学版),2014,39(4):365-370.
• [53]Antus B,Barta I.Relationship between exhaled nitric oxide and the frequency of severe acute exacerbation of COPD:3-year follow-up[J].Acta Physiol Hung,2013,100(4):469-477.
• [54]Durmaz D,Goksu E,Kilic T,et al.The role of nitric oxide in predicting revisit of patients with exacerbated chronic obstructive pulmonary disease[J].J Emerg Med,2015,48(2):247-253.
• [55]Lázár Z,Kelemená,Gálffy G,et al.Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease[J].J Breath Res,2018,12(3):036017.
• [56]Chou KT,Su KC,Huang SF,et al.Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD[J].Lung,2014,192(4):499-504.
• [57]Gao J,Zhang M,Zhou L,et al.Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD[J].Int J Chron Obstruct Pulmon Dis,2017,12:1287-1293.
• [58]Soter S,Barta I,Antus B.Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide[J].Inflammation,2013,36(5):1178-1185.
• [59]Cosio BG,Perez de Llano L,Lopez Viňa A,et al.Th-2 signature in chronic airway diseases:towards the extinction of asthma-COPD overlap syndrome?[J].Eur Respir J,2017,49(5).pii:1602397.
• [60]吉泽,潘星,姬峰,等.呼出气一氧化氮检测在哮喘-慢阻肺重叠综合征治疗中的应用价值[J].第二军医大学学报,2016,37(10):1250-1255.
• [61]Akamatsu K,Matsunaga K,Sugiura H,et al.Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease:What is the specific marker?[J].Front Pharmacol,2011,2:36.